Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-14

Clinical Trial Update: Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy [NA]

View source ↗

Summary

This clinical trial is evaluating selenium as an add-on therapy for mild-to-moderate Graves' ophthalmopathy (thyroid eye disease); the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Thyroid Eye Disease, Graves Ophthalmopathy | NA | Status: NOT_YET_RECRUITING